Replies to post #142056 on Biotech Values

[ronpopeil]

Looks very impressive imo. I'm not a scientist or a doctor but I like it.

[pcrutch]

"Abstract 6507: Single-agent ibrutinib showed a 73% ORR (65% PR 8% CR) in elderly (71 years 65-84) treatment naive patients with CLL at 10.7 months median follow-up."

This data is even more impressive when you consider 74% were older than 70.